Literature DB >> 9887992

Autoinhibition, sympathetic cotransmission and biphasic contractile responses to trains of nerve stimulation in the rodent vas deferens.

S Ventura1.   

Abstract

1. The present review critically discusses the evidence for and against the various hypotheses that have been proposed to explain the biphasic contractile response of the rodent vas deferens to trains of electrical field stimulation (EFS). 2. It is widely accepted that the initial component of the biphasic response of the rodent isolated vas deferens to trains of EFS is mediated by ATP and the second slower tonic contractions is mediated by noradrenaline (NA). This theory is based on the ability of antagonists of the post-junctional receptors for these neurotransmitters to inhibit the respective components of the biphasic response and on the ability of exogenous application of either ATP or NA to mimic the responses of each phase. 3. Prejunctional autoinhibition has also been proposed as the cause of the biphasic response. This is based primarily on the ability of alpha 2-adrenoceptor antagonists to transform responses from biphasic to monophasic and on the ability of neuronal NA uptake inhibitors to accentuate the separation of the two phases. 4. Atypical or extrajunctional NA receptors have also been proposed to be the mediators of the component of the response to nerve stimulation that is resistant to the traditional alpha-adrenoceptor antagonists. 5. Different contractile mechanisms and/or sources of calcium have also been postulated to cause the biphasic response. Blockers of intracellular Ca2+ mobilization are able to block the initial component, while blockers of extracellular Ca2+ entry inhibit the second tonic phase. 6. It is concluded that because alpha 1-adrenoceptor antagonists and blockers of P2 purinoceptors have also been shown to block both phases of the response to trains of EFS, prejunctional auto-inhibitory mechanisms perhaps provide the most sound explanation for the phenomenon of the biphasic contractile response to trains of EFS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9887992     DOI: 10.1111/j.1440-1681.1998.tb02169.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  8 in total

1.  Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens.

Authors:  A Christopoulos; P Coles; L Lay; M J Lew; J A Angus
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

2.  The effects of melatonin on electrical field stimulation-evoked biphasic twitch responses in the ipsilateral and contralateral rat vasa deferentia after unilateral testicular torsion/detorsion.

Authors:  Süreyya Barun; Gülşen Ekingen; Ismail Mert Vural; Zafer Türkyilmaz; Can Başaklar; Nuri Kale; Zeynep Sevim Ercan; Yusuf Sarioğlu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-08       Impact factor: 3.000

3.  Postnatal androgen deprivation dissociates the development of smooth muscle innervation from functional neurotransmission in mouse vas deferens.

Authors:  J A Brock; D J Handelsman; J R Keast
Journal:  J Physiol       Date:  2007-03-22       Impact factor: 5.182

4.  Adenosine 5'-triphosphate (ATP) is an excitatory cotransmitter with noradrenaline to the smooth muscle of the rat prostate gland.

Authors:  Sabatino Ventura; Ramila K Dewalagama; Linda C L Lau
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

5.  The effects of varicocele and its surgical correction on vas deferens motility.

Authors:  Arzu Demirtola; I Onur Ozen; Gokce S Ozturk; I Mert Vural; Sevim Ercan; Nuri Kale; Yusuf Sarioglu
Journal:  Pediatr Surg Int       Date:  2007-11-27       Impact factor: 1.827

6.  Effects of long-term treatment with haloperidol, clozapine and aripiprazole on mice isolated vas deferens.

Authors:  Mehmet Hanifi Tanyeri; Mehmet Emin Buyukokuroglu; Pelin Tanyeri; Oguz Mutlu; Füruzan Yildiz Akar; Güner Ulak; Bekir Faruk Erden
Journal:  Int Urol Nephrol       Date:  2017-07-03       Impact factor: 2.370

7.  Regulation of nerve-evoked contractions of rabbit vas deferens by acetylcholine.

Authors:  Audrey Wallace; Deborah Gabriel; Noel G McHale; Mark A Hollywood; Keith D Thornbury; Gerard P Sergeant
Journal:  Physiol Rep       Date:  2015-09

8.  Physiological and pharmacological aspects of the vas deferens-an update.

Authors:  David S Koslov; Karl-Erik Andersson
Journal:  Front Pharmacol       Date:  2013-08-22       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.